Growth Metrics

Nutex Health (NUTX) Equity Ratio (2016 - 2026)

Nutex Health (NUTX) has disclosed Equity Ratio for 17 consecutive years, with 0.46 as the latest value for Q1 2026.

  • For Q1 2026, Equity Ratio rose 37.83% year-over-year to 0.46; the TTM value through Mar 2026 reached 0.46, up 37.83%, while the annual FY2025 figure was 0.46, 60.24% up from the prior year.
  • Equity Ratio hit 0.46 in Q1 2026 for Nutex Health, roughly flat from 0.46 in the prior quarter.
  • Across five years, Equity Ratio topped out at 2.25 in Q1 2022 and bottomed at 0.18 in Q3 2024.
  • Average Equity Ratio over 5 years is 0.43, with a median of 0.29 recorded in 2024.
  • Year-over-year, Equity Ratio tumbled 88.68% in 2023 and then skyrocketed 149.62% in 2025.
  • Nutex Health's Equity Ratio stood at 0.28 in 2022, then decreased by 28.73% to 0.2 in 2023, then surged by 44.84% to 0.29 in 2024, then surged by 60.24% to 0.46 in 2025, then rose by 0.17% to 0.46 in 2026.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.46, 0.46, and 0.45 for Q1 2026, Q4 2025, and Q3 2025 respectively.